ConvaTec Group Management
Management criteria checks 3/4
ConvaTec Group's CEO is Karim Bitar, appointed in Sep 2019, has a tenure of 5.17 years. total yearly compensation is $5.44M, comprised of 22% salary and 78% bonuses, including company stock and options. directly owns 0.16% of the company’s shares, worth £7.70M. The average tenure of the management team and the board of directors is 4.2 years and 4.3 years respectively.
Key information
Karim Bitar
Chief executive officer
US$5.4m
Total compensation
| CEO salary percentage | 22.0% |
| CEO tenure | 5.2yrs |
| CEO ownership | 0.2% |
| Management average tenure | 4.2yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$153m |
| Mar 31 2024 | n/a | n/a | US$142m |
| Dec 31 2023 | US$5m | US$1m | US$130m |
| Sep 30 2023 | n/a | n/a | US$100m |
| Jun 30 2023 | n/a | n/a | US$70m |
| Mar 31 2023 | n/a | n/a | US$67m |
| Dec 31 2022 | US$5m | US$1m | US$63m |
| Sep 30 2022 | n/a | n/a | US$72m |
| Jun 30 2022 | n/a | n/a | US$80m |
| Mar 31 2022 | n/a | n/a | US$99m |
| Dec 31 2021 | US$5m | US$1m | US$118m |
| Sep 30 2021 | n/a | n/a | US$128m |
| Jun 30 2021 | n/a | n/a | US$139m |
| Mar 31 2021 | n/a | n/a | US$126m |
| Dec 31 2020 | US$4m | US$1m | US$113m |
| Sep 30 2020 | n/a | n/a | US$68m |
| Jun 30 2020 | n/a | n/a | US$24m |
| Mar 31 2020 | n/a | n/a | US$17m |
| Dec 31 2019 | US$9m | US$294k | US$10m |
Compensation vs Market: Karim's total compensation ($USD5.44M) is above average for companies of similar size in the UK market ($USD3.23M).
Compensation vs Earnings: Karim's compensation has been consistent with company performance over the past year.
CEO
Karim Bitar (59 yo)
5.2yrs
Tenure
US$5,435,794
Compensation
Mr. Karim Bitar serves as Chief Executive Officer and Director at Convatec Group Plc since September 30, 2019. Mr. Bitar served as the Chief Executive Officer of Genus plc from September 30, 2011 to Septem...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.2yrs | US$5.44m | 0.16% £ 7.7m | |
| Group CFO & Director | 2.7yrs | US$2.02m | 0.0024% £ 117.8k | |
| Executive VP and Chief Quality & Operations Officer | 2.8yrs | no data | no data | |
| Executive VP | 4.8yrs | no data | no data | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Executive VP | 3.6yrs | no data | no data | |
| Interim Chief People Officer | no data | no data | no data | |
| President & COO of Infusion Care | 6.8yrs | no data | no data | |
| President & COO of Global Advanced Wound Care | 4.8yrs | no data | no data | |
| President and COO of Continence Care & Home Services Group | 4.8yrs | no data | no data | |
| President & COO of Ostomy Care | 3.2yrs | no data | no data | |
| President & COO of Global Emerging Markets | 2.8yrs | no data | no data |
4.2yrs
Average Tenure
59.5yo
Average Age
Experienced Management: CTECL's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.2yrs | US$5.44m | 0.16% £ 7.7m | |
| Group CFO & Director | 2.7yrs | US$2.02m | 0.0024% £ 117.8k | |
| Independent Chairman | 5.2yrs | US$427.06k | 0.0011% £ 54.5k | |
| Independent Non-Executive Director | 4.3yrs | US$103.26k | 0.00049% £ 23.6k | |
| Independent Non-Executive Director | 2.8yrs | US$104.53k | 0.00049% £ 23.6k | |
| Senior Independent Director | 7.3yrs | US$154.25k | 0.00049% £ 23.6k | |
| Independent Non-Executive Director | 4.7yrs | US$124.93k | 0.0012% £ 58.9k | |
| Independent Non-Executive Director | 2.7yrs | US$117.28k | 0.00016% £ 7.7k | |
| Independent Non-Executive Director | 4.2yrs | US$99.44k | 0.0011% £ 55.0k |
4.3yrs
Average Tenure
60yo
Average Age
Experienced Board: CTECL's board of directors are considered experienced (4.3 years average tenure).